Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative AnalysisPamela Allen,Qing C Chen,Xinyan Lu,Kaitlyn O'Shea,Joan Chmiel,Madina Sukhanova,Liron Barnea Slonim,Hatice Savas,Eric Mou,Barbara Pro,Andrew M. Evens,Brett Alan Palmer,Ranjana Advani,Leo I. Gordon,Jane N. WinterBlood(2021)引用 3|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要